CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Study of Isatuximab (SAR650984) (NSC-795145) for Patients With Previously Treated AL Amyloidosis

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03499808
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:20.998160+00:00
Published At: 2025-02-27T00:00:00+00:00
Record Updated At: 2025-09-09
Results Posted At: 2025-02-27
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Amorphous, Eosinophilic, and Acellular Deposit", "Constipation", "Diarrhea", "Early Satiety", "Gastrointestinal Hemorrhage", "Hepatomegaly", "Lymphadenopathy", "Macroglossia", "Nausea", "Primary Systemic Amyloidosis", "Purpura", "Recurrent Primary Amyloidosis", "Refractory Primary Amyloidosis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-09-09"
protocolSection.identificationModule.nctId: "NCT03499808"
protocolSection.identificationModule.officialTitle: "A Phase II Study of Isatuximab (SAR650984) (NSC-795145) for Patients With Previously Treated AL Amyloidosis"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2025-02-27"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.